Epithelial to mesenchymal transition and breast cancer

被引：233

作者：

Tomaskovic-Crook, Eva ^{[1
]}

Thompson, Erik W. ^{[2
,3
]}

Thiery, Jean Paul ^{[1
]}

机构：

[1] Inst Mol & Cell Biol, Singapore 138673, Singapore

[2] St Vincents Inst Med Res, Melbourne, Vic 3065, Australia

[3] Univ Melbourne, Dept Surg, St Vincents Hosp, Melbourne, Vic 3065, Australia

来源：

BREAST CANCER RESEARCH | 2009年 / 11卷 / 06期

关键词：

CIRCULATING TUMOR-CELLS; BONE-MARROW MICROMETASTASIS; BASAL-LIKE PHENOTYPE; GENE-EXPRESSION; STEM-CELL; MAMMARY-TUMORS; METASTATIC-DISEASE; CLINICAL-RELEVANCE; HISTOLOGICAL GRADE; PROGNOSTIC-FACTOR;

D O I：

10.1186/bcr2416

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Epithelial-mesenchymal plasticity in breast carcinoma encompasses the phenotypic spectrum whereby epithelial carcinoma cells within a primary tumor acquire mesenchymal features and re-epithelialize to form a cohesive secondary mass at a metastatic site. Such plasticity has implications in progression of breast carcinoma to metastasis, and will likely influence response to therapy. The transcriptional and epigenetic regulation of molecular and cellular processes that underlie breast cancer and result in characteristic changes in cell behavior can be monitored using an increasing array of marker proteins. Amongst these markers exists the potential for emergent prognostic, predictive and therapeutic targeting.

引用

页数：10

共 88 条

[1] Ahmad A, 1998, AM J PATHOL, V152, P721
[2] The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity
Aigner, K.
Dampier, B.
Descovich, L.
Mikula, M.
Sultan, A.
Schreiber, M.
Mikulits, W.
Brabletz, T.
Strand, D.
Obrist, P.
Sommergruber, W.
Schweifer, N.
Wernitznig, A.
Beug, H.
Foisner, R.
Eger, A.
[J]. ONCOGENE, 2007, 26 (49) : 6979 - 6988
[3] Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Aktas, Bahriye
Tewes, Mitra
Fehm, Tanja
Hauch, Siegfried
Kimmig, Rainer
Kasimir-Bauer, Sabine
[J]. BREAST CANCER RESEARCH, 2009, 11 (04)
[4] Circulating tumor cells and bone marrow micrometastasis
Alix-Panabieres, Catherine
Riethdorf, Sabine
Pantel, Klaus
[J]. CLINICAL CANCER RESEARCH, 2008, 14 (16) : 5013 - 5021
[5] Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition
Arima, Yoshimi
Inoue, Yasumichi
Shibata, Tatsuhiro
Hayashi, Hidemi
Nagano, Osamu
Saya, Hideyuki
Taya, Yoichi
[J]. CANCER RESEARCH, 2008, 68 (13) : 5104 - 5112
[6] Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype
Balic, Marija
Lin, Henry
Young, Lillian
Hawes, Debra
Giuliano, Armando
McNamara, George
Datar, Ram H.
Cote, Richard J.
[J]. CLINICAL CANCER RESEARCH, 2006, 12 (19) : 5615 - 5621
[7] Clinical utility of cytokeratins as tumor markers
Barak, V
Goike, H
Panaretakis, KW
Einarsson, R
[J]. CLINICAL BIOCHEMISTRY, 2004, 37 (07) : 529 - 540
[8] Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer
Bedard, Philippe L.
de Azambuja, Evandro
Cardoso, Fatima
[J]. CURRENT CANCER DRUG TARGETS, 2009, 9 (02) : 148 - 162
[9] Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
Bidard, F. -C.
Vincent-Salomon, A.
Sigal-Zafrani, B.
Dieras, V.
Mathiot, C.
Mignot, L.
Thiery, J. -P.
Sastre-Garau, X.
Pierga, J. -Y.
[J]. ANNALS OF ONCOLOGY, 2008, 19 (03) : 496 - 500
[10] Disseminated tumor cells of breast cancer patients: A strong prognostic factor for distant and local relapse
Bidard, Francois-Clement
Vincent-Salomon, Anne
Gomme, Stephanie
Nos, Claude
de Rycke, Yann
Thiery, Jean Paul
Sigal-Zafrani, Brigitte
Mignot, Laurent
Sastre-Garau, Xavier
Pierga, Jean-Yves
[J]. CLINICAL CANCER RESEARCH, 2008, 14 (11) : 3306 - 3311

← 1 2 3 4 5 6 7 8 9 →